Biography

Mark helps providers of patient care and entities that conduct biomedical research understand, anticipate, and resolve regulatory compliance issues.

In the research arena, Mark provides counsel to universities, academic medical centers, biotech companies, and other research entities. Mark advises his clients regarding compliance with laws and regulations governing diverse aspects of pre-clinical and clinical research, including grants administration, conflicts of interest and transparency considerations, human subjects protection, research integrity, and U.S. Food and Drug Administration (FDA) restrictions on drug promotion. Mark assists hospitals and educational institutions with internal investigations into research misconduct allegations and also advises in connection with the development and implementation of organizational policies on individual and institutional conflicts of interest, compliance reporting systems, industry relations, and translational research collaborations.

In the realm of patient care, Mark has for many years counseled hospitals, health systems, and other health care providers concerning reimbursement and compliance issues. Mark has represented major medical centers, community hospitals, specialty hospitals, physicians, long-term care providers, laboratories, dialysis companies, and other health care entities regarding diverse aspects of Medicare and Medicaid billing and reimbursement, Public Health Service grants reimbursement, state and private insurer payment systems, and fraud and abuse laws. He litigated payment appeals at the Provider Reimbursement Review Board, U.S. Department of Health and Human Services (HHS) Departmental Appeals Board, and other public agencies, as well as in state and federal trial and appellate courts. He has also defended routine and special audits by Medicare Administrative Contractors and investigations by the HHS Office of the Inspector General and the Department of Justice.

Prior to joining Verrill, Mark was a special consultant to Harvard University, where he worked with the Office of the President and Provost to draft a University-wide policy on faculty conflicts of interest. He also consulted for Harvard Medical School, where he assisted the Office of Academic and Research Integrity and the University's Office of General Counsel in investigations of alleged research misconduct and conflicts of interest.

Mark lives with his wife, Ellen, an educator at the Concord Museum and the Boston Museum of Science, and with a shifting bestiary of pets. He devotes time to advocacy organizations for individuals with bleeding disorders and serves as the Secretary of the National Hemophilia Foundation. In his spare time, he loses himself in painting, at which he occasionally surprises. As a general matter, he can be guilted into almost any social cause, client need, or personal favor.

Services/Industries

Education

  • Harvard Law School  (J.D., cum laude)
  • Harvard University  (B.A., summa cum laude)
    • Phi Beta Kappa

Bar Admissions

  • Massachusetts

Honors

  • AV® rated by Martindale-Hubbell
  • Recognized in Chambers USA: America's Leading Lawyers for Business under Healthcare
  • Listed in The Best Lawyers in America© for Health Care Law in Boston, Massachusetts

To learn more about third-party ratings and rankings, and the selection processes used for inclusion, click here.

Firm Highlights

Matter

Aquaculture

Verrill represents both growers and coastal landowners regarding leasing and licensing of aquaculture enterprises.

Matter

Protection of Private Coastal Property Rights for Conservation of Intertidal Habitat

Verrill successfully represented coastal landowners in first-impression litigation against a Canadian seaweed harvesting company with global operations to determine who owns the sea plants that are growing on private intertidal property in Maine. In...

Publication/Podcast

More Proposed Changes to CCPA Geared to Health Care and Life Sciences Industries

The California Consumer Privacy Act of 2018 (“CCPA”) took effect on January 1, 2020. Days later on January 8, 2020, the California Senate Health Committee unanimously approved Senate bill A.B. 713 (the “Bill”) to...

Event

AHLA Academic Medical Centers and Teaching Hospitals Institute

In January, attorneys Kate Heffernan and Andrew Rusczek will be presenting at the American Health Lawyers Association's Academic Medical Centers and Teaching Hospitals Institute conference in Arlington, VA. The conference is designed to address...

Blog

First Circuit Acts on Appeal by South Portland Pipeline Company

On January 10, 2020, the U.S. Court of Appeals for the First Circuit acted on the Portland Pipe Line Corporation’s (PPLC) appeal of the district court order upholding a South Portland zoning ordinance that...

News

Verrill Elects Four New Partners

(January 22, 2020) – Verrill is pleased to announce that four of the firm’s attorneys have been elected to partner: Kristin Doeberl, Kelly Donahue, Christopher Lockman, and Mathew Todaro. Kristin Doeberl , a family...

News

Michael K. Fee to Lead Verrill’s Health Care and Life Sciences Defense Practice

(January 22, 2020) – Verrill is pleased to welcome Michael K. Fee to the firm’s Boston office as a Partner in its nationally recognized Health Care & Life Sciences Group and as the leader...

Publication/Podcast

Is the New U.S.-China Agreement What Was Prescribed?

The trade relationship between China and the United States has been top of mind for businesses over the past year. In spring 2018, Chinese President Xi Jinping denied the U.S. Government's request to end...

Event

Annual Employment Law Update: HR 2020 Vision for the Future

Blog

Annual Employment Law Update: HR 2020 - Vision for the Future